Max Healthcare Institute Ltd
Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]
- Market Cap ₹ 78,088 Cr.
- Current Price ₹ 803
- High / Low ₹ 910 / 438
- Stock P/E 73.9
- Book Value ₹ 80.7
- Dividend Yield 0.12 %
- ROCE 15.0 %
- ROE 16.1 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 115% CAGR over last 5 years
- Debtor days have improved from 38.6 to 26.9 days.
Cons
- Stock is trading at 9.96 times its book value
- Company has a low return on equity of 11.0% over last 3 years.
- Promoter holding has decreased over last 3 years: -46.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|
1,608 | 1,729 | 1,691 | 1,059 | 2,508 | 3,937 | 4,563 | 5,198 | |
1,467 | 1,616 | 1,535 | 965 | 2,101 | 2,986 | 3,322 | 3,747 | |
Operating Profit | 141 | 113 | 156 | 94 | 407 | 951 | 1,241 | 1,451 |
OPM % | 9% | 7% | 9% | 9% | 16% | 24% | 27% | 28% |
59 | 65 | 56 | 48 | -122 | 110 | 139 | 173 | |
Interest | 100 | 99 | 101 | 83 | 179 | 101 | 84 | 59 |
Depreciation | 96 | 94 | 103 | 46 | 174 | 221 | 232 | 235 |
Profit before tax | 5 | -15 | 8 | 13 | -69 | 739 | 1,064 | 1,330 |
Tax % | -236% | -65% | 102% | -1% | -67% | 18% | -4% | |
16 | -25 | -0 | 59 | -138 | 605 | 1,104 | 1,057 | |
EPS in Rs | 0.29 | -0.47 | -0.06 | 1.10 | -1.42 | 6.24 | 11.37 | 10.88 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 9% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 21% |
3 Years: | 63% |
TTM: | 21% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 115% |
3 Years: | 165% |
TTM: | 8% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 53% |
1 Year: | 84% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 11% |
Last Year: | 16% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 |
Reserves | 655 | 627 | 426 | 2,016 | 4,673 | 5,313 | 6,439 | 6,874 |
874 | 981 | 1,003 | 875 | 1,101 | 913 | 689 | 660 | |
1,080 | 1,157 | 1,389 | 546 | 1,803 | 1,993 | 2,003 | 2,150 | |
Total Liabilities | 3,146 | 3,302 | 3,355 | 3,974 | 8,543 | 9,189 | 10,102 | 10,656 |
2,244 | 2,227 | 2,192 | 851 | 6,536 | 7,018 | 7,039 | 7,126 | |
CWIP | 46 | 38 | 87 | 28 | 27 | 151 | 252 | 254 |
Investments | 0 | 0 | 1 | 2,182 | 1 | 1 | 1 | 1 |
856 | 1,036 | 1,075 | 913 | 1,980 | 2,020 | 2,810 | 3,276 | |
Total Assets | 3,146 | 3,302 | 3,355 | 3,974 | 8,543 | 9,189 | 10,102 | 10,656 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|
156 | 166 | 89 | 77 | 118 | 741 | 1,209 | |
-104 | -124 | -17 | -2,641 | 206 | -764 | -1,187 | |
-48 | -48 | -74 | 2,353 | 191 | -294 | -289 | |
Net Cash Flow | 4 | -6 | -2 | -210 | 516 | -317 | -266 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|
Debtor Days | 53 | 59 | 78 | 33 | 53 | 36 | 27 |
Inventory Days | 20 | 24 | 26 | 43 | 34 | 24 | 30 |
Days Payable | 184 | 227 | 292 | 286 | 274 | 174 | 212 |
Cash Conversion Cycle | -111 | -144 | -188 | -210 | -187 | -114 | -155 |
Working Capital Days | 7 | -2 | -136 | 116 | -32 | -13 | -39 |
ROCE % | 4% | 6% | 4% | 7% | 12% | 15% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
2d - On acquisition of additional equity stake in Sandhya Hydro Power Projects Balargha Private Limited
- Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 19 Apr
- Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 16 Apr
- Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 10 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
6 Apr - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Annual reports
Concalls
-
Feb 2024Transcript PPT
-
Jan 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Jun 2022TranscriptPPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
May 2021Transcript PPT
-
Mar 2021TranscriptPPT
-
Feb 2021Transcript PPT
-
Feb 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Sep 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
Leadership[1]
Max Healthcare is India’s second largest hospital chain in terms of revenue, EBITDA and market capitalisation.